Brief: Cipla Receives U.S. FDA Approval For First AB-Rated Generic Of Ventolin® Hfa
23/04/2026 16:25
April 23 (Reuters) - Cipla Ltd CIPL.NS: CIPLA RECEIVES U.S. FDA APPROVAL FOR FIRST AB-RATED GENERIC OF VENTOLIN® HFA Source text: ID:nPn7l5ygca Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate